← back to search

Wei Keat Lim

Regeneron (United States) · US
Area of research
Immunology · Molecular Biology
Research interest
Research interests include IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, Asthma and respiratory diseases, and Bioinformatics and Genomic Networks.
h-index
25
citations
6,843
works
94
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
Allergy 2024cited by 30position: middledoi
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis
European Respiratory Journal 2023cited by 32position: middledoi
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
New England Journal of Medicine 2022cited by 445position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2024–2024)— · 1 papers (2023–2023)— · 1 papers (2023–2023)— · 1 papers (2023–2023)— · 1 papers (2023–2023)— · 1 papers (2023–2023)Matthew F. Wipperman · Regeneron (United States)1 papers (2024–2024)— · 1 papers (2023–2023)Camille Taillé · Université Claude Bernard Lyon 11 papers (2023–2023)— · 1 papers (2023–2023)Vincent Cottin · Hôpital Avicenne1 papers (2023–2023)— · 1 papers (2023–2023)— · 1 papers (2023–2023)Elizabeth Laws · Sanofi (United States)1 papers (2024–2024)S. Grootenboer‐Mignot · Université Claude Bernard Lyon 11 papers (2023–2023)— · 1 papers (2024–2024)Sara Hamon · Rockefeller University1 papers (2024–2024)Jonathan Corren · APLA Health1 papers (2024–2024)Jennifer Maloney · Progenics Pharmaceuticals (United States)1 papers (2024–2024)Edouard Guenzi · Université Claude Bernard Lyon 11 papers (2023–2023)